Phorbol ester up-regulates aldose reductase expression in A549 cells: A potential role for aldose reductase in cell cycle modulation

Cellular and Molecular Life Sciences

Volumn 62, Issue 10, 2005, Pages 1146-1155

  Kang, E S ^a   Kim, H J ^a   Paek, K S ^b   Jang, H S ^a   Chang, K C ^a   Lee, J H ^a   Nishinaka, T ^c   Yabe Nishimura, C ^c   Seo, H G ^a  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Semyung University   (South Korea)

^c KYOTO PREFECTURAL UNIVERSITY OF MEDICINE   (Japan)

Author keywords

Aldose reductase; Cancer; Nuclear factor B; Phorbol ester; Protein kinase C

Indexed keywords

1 BENZYL 3 HYDROXY 2(5H) OXOPYRROLE 4 CARBOXYLATE; AG 18; ALDEHYDE REDUCTASE; ALDOSE REDUCTASE INHIBITOR; BENZYLOXYCARBONYLLEUCYLLEUCYLLEUCINAL; BISINDOLYLMALEIMIDE; CYCLOHEXIMIDE; DACTINOMYCIN; GENISTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MESSENGER RNA; PHORBOL 13 ACETATE 12 MYRISTATE; PHORBOL ESTER; PROTEIN KINASE C; PROTEIN KINASE INHIBITOR; PROTEIN TYROSINE KINASE; PYRROLIDINE DITHIOCARBAMATE; TUMOR PROMOTER; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CELL CYCLE; CELL CYCLE S PHASE; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE EXPRESSION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; STATISTICAL SIGNIFICANCE;

ALDEHYDE REDUCTASE; CELL CYCLE; CELL LINE, TUMOR; CYCLOHEXIMIDE; DACTINOMYCIN; ENZYME INHIBITORS; GENE EXPRESSION; HUMANS; NF-KAPPA B; PROMOTER REGIONS (GENETICS); PROTEIN KINASE C; PROTEIN KINASE INHIBITORS; PROTEIN-TYROSINE KINASES; PYRROLIDONECARBOXYLIC ACID; SIGNAL TRANSDUCTION; TETRADECANOYLPHORBOL ACETATE; UP-REGULATION;

EID: 21044442605     PISSN: 1420682X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00018-005-5024-4     Document Type: Article

References (41)

1. Jez J. M., Flynn T. G. and Penning T. M. (1997) A new nomenclature for the aldo-keto reductase superfamily. Biochem. Pharmacol. 54: 639-647
2. Kinoshita J. H. and Nishimura C. (1988) The involvement of aldose reductase in diabetic complications. Diabetes Metabol. Rev. 4: 323-337
3. Yabe-Nishimura C. (1998) Aldose reductase in glucose toxicity: a potential target for the prevention of diabetic complications. Pharmacol. Rev. 50: 21-33
4. Vander Jagt D. L., Robinson B., Taylor K. K. and Hunsaker L. A. (1992) Reduction of trioses by NADPH-dependent aldoketo reductases: aldose reductase, methylglyoxal, and diabetic complications. J. Biol. Chem. 267: 4364-4369
5. Kolb N. S., Hunsaker L. A. and Vander Jagt D. L. (1994) Aldose reductase-catalyzed reduction of acrolein: implications in cyclophosphamide toxicity. Mol. Pharmacol. 45: 797-801
6. Vander Jagt D. L., Kolb N. S., Vander Jagt T. J., Chino J., Martinez F. J., Hunsaker L. A. et al. (1995) Substrate specificity of human aldose reductase: identification of 4-hydroxynonenal as an endogenous substrate. Biochim. Biophys. Acta 1249: 117-126
7. Aguilera J. and Prieto J. A. (2001) The Saccharomyces cerevisiae aldose reductase is implied in the metabolism of methylglyoxal in response to stress conditions. Curr. Genet. 39: 273-283
8. Zeindl-Eberhart E., Jungblut P. R., Otto A. and Rabes H. M. (1994) Identification of tumor-associated protein variants during rat hepatocarcinogenesis: aldose reductase. J. Biol. Chem. 269: 14589-14594
9. Zeindl-Eberhart E., Haraida S., Liebmann S., Jungblut P. R., Lamer S., Mayer D. et al. (2004) Detection and identification of tumor-associated protein variants in human hepatocellular carcinomas. Hepatology 39: 540-549
10. Takahashi M., Fujii J., Miyoshi E., Hoshi A. and Taniguchi N. (1995) Elevation of aldose reductase gene expression in rat primary hepatoma and hepatoma cell lines: implication in detoxification of cytotoxic aldehydes. Int. J. Cancer 62: 749-754
11. Behnia K. and Boroujerdi M. (1999) Inhibition of aldo-keto reductases by phenobarbital alters metabolism, pharmacokinetics and toxicity of doxorubicin in rats. J. Pharm. Pharmacol. 51: 1275-1282
12. Lee K. W., Ko B. C., Jiang Z., Cao D. and Chung S. S. (2001) Overexpression of aldose reductase in liver cancers may contribute to drug resistance. Anticancer Drugs 12: 129-132
13. Lee E. K., Regenold W. T. and Shapiro P. (2002) Inhibition of aldose reductase enhances HeLa cell sensitivity to chemotherapeutic drugs and involves activation of extracellular signal-regulated kinases. Anticancer Drugs 13: 859-868
14. Ramana K. V., Bhatnagar A. and Srivastava S. K. (2004) Inhibition of aldose reductase attenuates TNF-alpha-induced expression of adhesion molecules in endothelial cells. FASEB J. 18: 1209-1218
15. Ramana K. V., Friedrich B., Srivastava S., Bhatnagar A. and Srivastava S. K. (2004) Activation of nuclear factor-kappaB by hyperglycemia in vascular smooth muscle cells is regulated by aldose reductase. Diabetes 53: 2910-2920
16. Chang K. C., Paek K. S., Kim H. J., Lee Y. S., Yabe-Nishimura C. and Seo H. G. (2002) Substrate-induced up-regulation of aldose reductase by methylglyoxal, a reactive oxoaldehyde elevated in diabetes. Mol. Pharmacol. 61: 1184-1191
17. Nishinaka T. and Yabe-Nishimura C. (2001) EGF receptor-ERK pathway is the major signaling pathway that mediates upregulation of aldose reductase expression under oxidative stress. Free Radie. Biol. Med. 31: 205-216
18. Chomczynski P. and Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal. Biochem. 162: 156-159
19. Nishimura C., Yamaoka T., Mizutani M., Yamashita K., Akera T. and Tanimoto T. (1991) Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim. Biophys. Acta 1078: 171-178
20. Ji C., Kozak K. R. and Marnett L. J. (2001) IkappaB kinase, a molecular target for inhibition by 4-hydroxy-2-nonenal. J. Biol. Chem. 276: 18223-18228
21. Nishimura C., Hamada Y., Tachikawa T., Ishikawa T., Gui T., Tsubouchi J. et al. (1994) Enzyme immunoassay for erythrocyte aldose reductase. Clin. Chem. 40: 889-894
22. Li H., Nobukuni Y., Gui T. and Yabe-Nishimura C. (1999) Characterization of genomic regions directing the cell-specific expression of the mouse aldose reductase gene. Biochem. Biophys. Res. Commun. 255: 759-764
23. Iwata T., Sato S., Jimenez J., McGowan M., Moroni M., Dey A. et al. (1999) Osmotic response element is required for the induction of aldose reductase by tumor necrosis factor-alpha. J. Biol. Chem. 274: 7993-8001
24. Fournier A. and Murray A. W. (1987) Application of phorbol ester to mouse skin causes a rapid and sustained loss of protein kinase C. Nature 330: 767-769
25. Li J. M., Mullen A. M., Yun S., Wientjes F., Brouns G. Y., Thrasher A. J. et al. (2002) Essential role of the NADPH oxidase subunit p47(phox) in endothelial cell superoxide production in response to phorbol ester and tumor necrosis factor-alpha. Circ. Res. 90: 143-150
26. Seo H. G., Nishinaka T. and Yabe-Nishimura C. (2000) Nitric oxide up-regulates aldose reductase expression in rat vascular smooth muscle cells: a potential role for aldose reductase in vascular remodeling. Mol. Pharmacol. 57: 709-717
27. Aruoma O. I., Halliwell B., Hoey B. M. and Butler J. (1989) The antioxidant action of N-acetylcysteine: its reaction with hydrogen peroxide, hydroxyl radical, superoxide, and hypochlorous acid. Free Radic. Biol. Med. 6: 593-597
28. Chen C. C., Chen J. J. and Chou C. Y. (2000) Protein kinase calpha but not p44/42 mitogen-activated protein kinase, p38, or c-Jun NH(2)-terminal kinase is required for intercellular adhesion molecule-1 expression mediated by interleukin-1beta: involvement of sequential activation of tyrosine kinase, nuclear factor-kappaB-inducing kinase, and IkappaB kinase 2. Mol. Pharmacol. 58: 1479-1489
29. Chen C., Chou C., Sun Y. and Huang W. (2001) Tumor necrosis factor alpha-induced activation of downstream NF-kappaB site of the promoter mediates epithelial ICAM-1 expression and monocyte adhesion: involvement of PKCalpha, tyrosine kinase, and IKK2, but not MAPKs, pathway. Cell Signal. 13: 543-553
30. Chen C. C. and Wang J. K. (1999) p38 but not p44/42 mitogen-activated protein kinase is required for nitric oxide synthase induction mediated by lipopolysaccharide in RAW 264.7 macrophages. Mol. Pharmacol. 55: 481-488
31. Tanaka K., Kawakami T., Tateishi K., Yashiroda H. and Chiba T. (2001) Control of IkappaBalpha proteolysis by the ubiquitin-proteasome pathway. Biochimie 83: 351-356
32. Jacquin-Becker C. and Labourdette G. (1997) Regulation of aldose reductase expression in rat astrocytes in culture. Glia 20: 135-144
33. Hsu D. K., Guo Y., Peifley K. A. and Winkles J. A. (1997) Differential control of murine aldose reductase and fibroblast growth cells by FGF-1 treatment and hyperosmotic stress. Biochem. J. 328: 593-598
34. Bhatnagar A., Ruef J., Liu S., Srivastava S. and Srivastava S. K. (2001) Regulation of smooth muscle cell growth by aldose reductase. Chem. Biol. Interact. 130-132: 627-636
35. Ruef J., Liu S. Q., Bode C., Tocchi M., Srivastava S., Runge M. S. et al. (2000) Involvement of aldose reductase in vascular smooth muscle cell growth and lesion formation after arterial injury. Arterioscler. Thromb. Vasc. Biol. 20: 1745-1752
36. Zeindl-Eberhart E., Klugbauer S., Dimitrijevic N., Jungblut P. R., Lamer S. and Rabes H. M. (2001) Proteome analysis of rat hepatomas: carcinogen-dependent tumor-associated protein variants. Electrophoresis 22: 3009-3018
37. Seow T. K., Ong S. E., Liang R. C., Ren E. C., Chan L., Ou K. et al. (2000) Two-dimensional electrophoresis map of the human hepatocellular carcinoma cell line, HCC-M, and identification of the separated proteins by mass spectrometry. Electrophoresis 21: 1787-1813
38. Wirth P. J., Hoang T. N. and Benjamin T. (1995) Micropreparative immobilized pH gradient two-dimensional electrophoresis in combination with protein microsequencing for the analysis of human liver proteins. Electrophoresis 16: 1946-1960
39. Yu L. R., Zeng R., Shao X. X., Wang N., Xu Y. H. and Xia Q. C. (2000) Identification of differentially expressed proteins between human hepatoma and normal liver cell lines by two-dimensional electrophoresis and liquid chromatography-ion trap mass spectrometry. Electrophoresis 21: 3058-3068
40. Rittner H. L., Hafner V., Klimiuk P. A., Szweda L. I., Goronzy J. J. and Weyand C. M. (1999) Aldose reductase functions as a detoxification system for lipid peroxidation products in vasculitis. J. Clin. Invest. 103: 1007-1013
41. Spycher S. E., Tabataba-Vakili S., O'Donnell V. B., Palomba L. and Azzi A. (1997) Aldose reductase induction: a novel response to oxidative stress of smooth muscle cells. FASEB J. 11: 181-188